Private Market View

Encellin

Biotechnology

Last price · $/share
Implied valuation
Total raised
$2.1M
Last round
Early Stage VC
Sep 2023
Valuation — not yet established

No valuation for Encellin is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($2.1M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
  • ·Post-money valuations for all 3 rounds
  • ·Watchlist + deal alerts for Encellin
Create free account
No card required

Funding history

3 rounds
DateRoundRaisedPost-money
Sep 2023Early Stage VC$9.9M
Aug 2021Seed Round$2.1M
Jun 2019Seed Round$2.1M

How Encellin's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Encellin, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

How much has Encellin raised?
Encellin has raised $2.1M in total funding across 3 recorded rounds.
When did Encellin last raise?
Encellin last raised in Sep 2023 (Early Stage VC), raising $9.9M.